Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat
Authors
Keywords
-
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 45, Issue 3, Pages 489-495
Publisher
Springer Science and Business Media LLC
Online
2021-10-14
DOI
10.1007/s40618-021-01687-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sympatholytic Mechanisms for the Beneficial Cardiovascular Effects of SGLT2 Inhibitors: A Research Hypothesis for Dapagliflozin’s Effects in the Adrenal Gland
- (2021) Anastasios Lymperopoulos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does epicardial fat contribute to COVID-19 myocardial inflammation?
- (2020) Alexis Elias Malavazos et al. EUROPEAN HEART JOURNAL
- Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity
- (2020) Gianluca Iacobellis et al. Obesity
- Epicardial Fat Inflammation in Severe COVID‐19
- (2020) Gianluca Iacobellis et al. Obesity
- Is epicardial fat attenuation a novel marker of coronary inflammation?
- (2019) Gianluca Iacobellis et al. ATHEROSCLEROSIS
- Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: A target to modulate cardiovascular risk?
- (2019) Elena Dozio et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones and Regional Body Fat Stores in Adults with Obesity
- (2019) Hoda Kadouh et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of dapagliflozin treatment on epicardial adipose tissue volume
- (2018) Takao Sato et al. Cardiovascular Diabetology
- Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
- (2018) Milton Packer JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of liraglutide, metformin, and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial
- (2018) Wen-Huan Feng et al. Journal of Diabetes Investigation
- Epicardial fat in heart failure patients with mid-range and preserved ejection fraction
- (2018) Gijs van Woerden et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Epicardial Fat Expresses Glucagon-Like Peptide 1 and 2 Receptors Genes
- (2017) Gianluca Iacobellis et al. HORMONE AND METABOLIC RESEARCH
- Novel atherogenic pathways from the differential transcriptome analysis of diabetic epicardial adipose tissue
- (2017) V. Camarena et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Epicardial adipose tissue is related to cardiac function in elderly women, but not in men
- (2017) Su-A Kim et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Liraglutide causes large and rapid epicardial fat reduction
- (2017) Gianluca Iacobellis et al. Obesity
- Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
- (2017) Shusuke Yagi et al. Diabetology & Metabolic Syndrome
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events
- (2017) Kenneth W. Mahaffey et al. CIRCULATION
- Chronic Heart Failure and Inflammation
- (2016) Sarah A. Dick et al. CIRCULATION RESEARCH
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
- (2016) A. Dutour et al. DIABETES OBESITY & METABOLISM
- Inflammation in Heart Failure
- (2016) Jawahar L. Mehta et al. HYPERTENSION
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study
- (2015) Susanna Morano et al. ACTA DIABETOLOGICA
- Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location
- (2015) Bénédicte Gaborit et al. CARDIOVASCULAR RESEARCH
- Evaluating the Atrial Myopathy Underlying Atrial Fibrillation
- (2015) Jeffrey J. Goldberger et al. CIRCULATION
- Local and systemic effects of the multifaceted epicardial adipose tissue depot
- (2015) Gianluca Iacobellis Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease
- (2015) Elizabeth A. McAninch et al. Obesity
- Adipocyte Inflammation Is Essential for Healthy Adipose Tissue Expansion and Remodeling
- (2014) Ingrid Wernstedt Asterholm et al. Cell Metabolism
- GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK
- (2014) D. Beiroa et al. DIABETES
- Association of Epicardial Adipose Tissue With Progression of Coronary Artery Calcification Is More Pronounced in the Early Phase of Atherosclerosis
- (2014) Amir A. Mahabadi et al. JACC-Cardiovascular Imaging
- Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes
- (2013) JUNPENG YANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Adult Epicardial Fat Exhibits Beige Features
- (2013) Harold S. Sacks et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
- (2013) Erika Paniago Guedes et al. Diabetology & Metabolic Syndrome
- The Glucagon-Like Peptide-1 Receptor—or Not?
- (2012) Charles Pyke et al. ENDOCRINOLOGY
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Association Between Epicardial Adipose Tissue Volumes on 3-Dimensional Reconstructed CT Images and Recurrence of Atrial Fibrillation After Catheter Ablation
- (2011) Koichi Nagashima et al. CIRCULATION JOURNAL
- Myocardial, Perivascular, and Epicardial Fat
- (2011) P. Iozzo DIABETES CARE
- Study of the Potential Association of Adipose Tissue GLP-1 Receptor with Obesity and Insulin Resistance
- (2011) Joan Vendrell et al. ENDOCRINOLOGY
- Coronary Atherosclerosis Is Associated With Macrophage Polarization in Epicardial Adipose Tissue
- (2011) Yoichiro Hirata et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)
- (2011) I. Kimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features
- (2011) Gianluca Iacobellis et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Relation of Echocardiographic Epicardial Fat Thickness and Myocardial Fat
- (2010) Alexis Elias Malavazos et al. AMERICAN JOURNAL OF CARDIOLOGY
- Epicardial Adipokines in Obesity and Coronary Artery Disease Induce Atherogenic Changes in Monocytes and Endothelial Cells
- (2010) Kalypso Karastergiou et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Epicardial fat thickness and coronary artery disease correlate independently of obesity
- (2010) Gianluca Iacobellis et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Myocardial Fatty Acid Metabolism in Health and Disease
- (2010) Gary D. Lopaschuk et al. PHYSIOLOGICAL REVIEWS
- Epicardial adipose tissue and coronary artery plaque characteristics
- (2009) Nikolaos Alexopoulos et al. ATHEROSCLEROSIS
- Uncoupling Protein-1 and Related Messenger Ribonucleic Acids in Human Epicardial and Other Adipose Tissues: Epicardial Fat Functioning as Brown Fat
- (2009) Harold S. Sacks et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Secretory Type II Phospholipase A2 Is Produced and Secreted by Epicardial Adipose Tissue and Overexpressed in Patients with Coronary Artery Disease
- (2009) Anne Dutour et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Echocardiographic Epicardial Fat: A Review of Research and Clinical Applications
- (2009) Gianluca Iacobellis et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women
- (2007) A. M. de Vos et al. EUROPEAN HEART JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now